These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 3144037)
1. [Acquired hemophilia. Apropos of a case report with a fatal course]. de Moerloose P; Tissot JD; Reber G; Schifferli J; Vogel J; Bouvier CA Schweiz Med Wochenschr; 1988 Oct; 118(42):1542-5. PubMed ID: 3144037 [TBL] [Abstract][Full Text] [Related]
2. [Long-term remission after i.v. immunoglobulin therapy in acquired antihemophilic factor hemophilia with systemic lupus erythematosus]. Pirner K; Rösler W; Kalden JR; Manger B Z Rheumatol; 1990; 49(6):378-81. PubMed ID: 2128157 [TBL] [Abstract][Full Text] [Related]
4. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management. Mahasandana C; Patharathienskul D; Suvatte V Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549 [TBL] [Abstract][Full Text] [Related]
5. Evidence of the direct interaction between spontaneously occurring anti-factor VIII autoantibody and intravenous immunoglobulin. Nishida Y; Sakiyama N; Kakishita E; Nagai K Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):134-9. PubMed ID: 2500823 [TBL] [Abstract][Full Text] [Related]
6. [Development of factor VIII inhibitor in three non-hemophiliac patients]. Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439 [TBL] [Abstract][Full Text] [Related]
7. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII]. Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666 [TBL] [Abstract][Full Text] [Related]
8. Severe bleeding in a case of acquired factor VIII inhibitor associated with generalized pustular psoriasis. Merlini M; Moccia F; Delucchi M; Grillo G Ann Ital Med Int; 2005; 20(4):248-52. PubMed ID: 16610257 [TBL] [Abstract][Full Text] [Related]
9. [Hemorrhagic syndrome associated with a factor VIII:C inhibitor in a patient with lymphoma]. Casas E; García Puig J; Villar A; González Sanz A; Miranda ME; Ortiz Vázquez J Med Clin (Barc); 1989 Jun; 93(1):23-5. PubMed ID: 2505004 [TBL] [Abstract][Full Text] [Related]
10. [Macrohaematuria post-partum: an unusual case of acquired haemophilia after pregnancy]. Prencipe MA; D'Errico M; Di Giorgio G; Gatta G; Gesuete A; Nobile M; Stallone C G Ital Nefrol; 2002; 19(2):204-8. PubMed ID: 12195420 [TBL] [Abstract][Full Text] [Related]
11. Bedside measurement of factor VIII:C activity in individuals with hemophilia A. Kessler CM; Bernstein Z; Ghesani S; Shamsipour Z; Frances C; Zucker ML; LaDuca FM Am J Hematol; 1996 Mar; 51(3):181-5. PubMed ID: 8619397 [TBL] [Abstract][Full Text] [Related]
12. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia]. Meili EO; Dazzi H; von Felten A Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567 [TBL] [Abstract][Full Text] [Related]
13. Severe acquired hemophilia with factor VIII inhibition associated with acetaminophen and chlorpheniramine. Famularo G; De Maria S; Minisola G; Nicotra GC Ann Pharmacother; 2004 Sep; 38(9):1432-4. PubMed ID: 15266042 [TBL] [Abstract][Full Text] [Related]
14. Successful rituximab therapy of acquired factor VIII inhibitor in a patient with rheumatoid arthritis. Oliveira B; Arkfeld DG; Weitz IC; Shinada S; Ehresmann G J Clin Rheumatol; 2007 Apr; 13(2):89-91. PubMed ID: 17414538 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A. Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320 [TBL] [Abstract][Full Text] [Related]
16. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy. Kubisz P; Plamenová I; Hollý P; Stasko J Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019 [TBL] [Abstract][Full Text] [Related]
17. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases]. Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies]. Gassmann AE; Kerkhofs H; Leeksma CH Schweiz Med Wochenschr; 1970 Oct; 100(41):1734-6. PubMed ID: 5480542 [No Abstract] [Full Text] [Related]
19. [Non-hemophilic patient with inhibitor against factor VIII produced after the second delivery]. Akahori M; Yamane T; Hino M; Ohta K; Takubo T; Samori T; Tatsumi N Rinsho Byori; 1999 Sep; 47(9):891-5. PubMed ID: 10518429 [TBL] [Abstract][Full Text] [Related]
20. New protocol for immune tolerance induction in acquired hemophilia. Nemes L; Pitlik E Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]